June 8^th from 12:30 to 13:15 in the Main Arena 1
Lunch symposium : The Alvimedica drug approach to the treatment of the lower limb lesions
Moderator: Ralf Langhoff
Panel: Andrea Kahlberg, Stefan Müller-Hülsbeck, Marco Manzi, Marc Sirvent
 
June 8^th   from 12:30 to 13:15 in the Main Arena 1
Lunch symposium : The Alvimedica drug approach to the treatment of the lower limb lesions
Moderator: Ralf Langhoff
Panel: Andrea Kahlberg, Stefan Müller-Hülsbeck, Marco Manzi, Marc Sirvent
 
     12:30 Introduction and objectives – Ralf Langhoff
     12:32 Amphilimus™: not only a pure drug option – Andrea Kahlberg
     12:39 Focus on SFA: What we know and what we don’t know about the use of Sirolimus  - Stefan Müller-Hülsbeck
     12:46 Focus on SFA. The NiTiDES™ solution – Andrea Kahlberg
     12:53 Focus on BTK: DES role in the treatment of lower limb lesions – Marco Manzi
     13:00 Focus on BTK. My personal experience with Cre8™ BTK – Marc Sirvent
     13:07 Discussion
     13:13 Take-home messages and closure – Ralf Langhoff
 
 
June 7^th  from 11:15 to 12:30 in the Speakers corner
During the session: “Latest clinical data and original research papers: Femoropopliteal – Part I”
At 12:00 speech by Prof. Dierk Scheinert titled “NiTiDES™: Sirolimus Self-Expanding DES technology and clinical study update
 

June 8^th from 09:45 to 11:00 in the Speakers corner
During the session: “Latest clinical data and original research papers: CLTI – Part I”
At 10:45 speech by Dr. Marc Sirvent  titled “Cre8™ BTK clinical results in below the knee complex patients”